Document is current

Article History

Received: 20 March 2023

Accepted: 19 July 2023

First Online: 5 August 2023

Declarations

:

: The study was reviewed and the need for approval was waived by the board of the Medical Ethics Committee of the VU Medical Center, Amsterdam UMC. All participants gave informed consent before participation.

: Not applicable.

: HH, AG, TH, FM, AK, and MK report no financial disclosures or conflicts of interest. AH Research is funded by Alzheimer Nederland and the VUmc fund. AH is a consultant to Roche Diagnostics. All funding is paid to her institution. HRM performs contract research for Combinostics; all funding is paid to her institution. WF Research programs of Wiesje van der Flier have been funded by ZonMW, NWO, EU-FP7, EU-JPND, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health ~ Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, stichting Alzheimer & Neuropsychiatrie Foundation, Philips, Biogen MA Inc, Novartis-NL, Life-MI, AVID, Roche BV, Fujifilm, Combinostics. WF holds the Pasman chair. WF has performed contract research for Biogen MA Inc, and Boehringer Ingelheim. WF has been an invited speaker at Boehringer Ingelheim, Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), NovoNordisk, Springer Healthcare, European Brain Council. WF is a consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA Inc. WF participated in advisory boards of Biogen MA Inc, Roche, and Eli Lilly. All funding is paid to her institution. WF is a member of the steering committee of PAVE, and Think Brain Health. WF was associate editor of Alzheimer, Research & Therapy in 2020/2021. WF is an associate editor at Brain. Leonie Visser (LNCV) has been an invited speaker at Schwabe Group, fees were paid to her institution.